Project Description


Head Office – UK
Website(Owned by)
Client – Finance Director (retiring)
– Finance Director
Practice – Search
Size – SME
Industry – Life Sciences


Proximagen is the drug discovery and development subsidiary of US-based Upsher-Smith Laboratories Inc, a fully-integrated pharmaceutical company whose mission is to deliver high-value, high-quality therapies and solutions that measurably improve patients’ lives. Located in Cambridge, UK, Proximagen has in-house capabilities in all core drug discovery disciplines, including medicinal chemistry, biology, drug metabolism and pharmacokinetics (DMPK). Proximagen is focused on developing small molecule therapeutics addressing a number of indications but primarily, diseases of the central nervous system.


“After spending many successful years with Proximagen, helping the company go through a flotation and subsequent sale, it was time for me move on. I needed to find a Finance Director to replace me – one that was comfortable operating within the SME environment but also appreciated the requirements of reporting to a large conglomerate. Proximagen had been sold to Upsher-Smith Laboratories, so there was a requirement of the new Finance Director to help the local management team run and grow the company within the confines of the parent company. In fdu I found not only a search partner that was able to comprehensively scour the UK market place within the relevant industry sector, but an energised team that fully appreciated the need for a strong cultural fit and a finalist Candidate who would be involved in managing the company. fdu’s timely and accurate advice made the process as seamless as possible, with great results.”

James Hunter, Former Finance Director